StockData
CV Sciences, Inc. logo

CV Sciences, Inc. (CVSI) stock

CVSIOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 7/30
$0.01−0.00 (-21.13%)

Close on Oct 19, 2026Market cap $2.53MP/E –Yield –

CV Sciences enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

CV Sciences's enterprise value was $2.14M on Oct 19, 2026, against $6.06M a year earlier. Over the last 5 years it ranged from $1.24M to $18.13M, with a median of $6.04M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Oct 19, 2026$2.14M-82.0%
2025Dec 31, 2025$11.89M+126.5%
2024Dec 31, 2024$5.25M+15.6%
2023Dec 29, 2023$4.54M+35.0%
2022Dec 30, 2022$3.36M-70.8%
2021Dec 31, 2021$11.53M-73.8%
2020Dec 31, 2020$43.99M-46.4%
2019Dec 31, 2019$82.07M-79.3%
2018Dec 31, 2018$395.66M+644.9%
2017Dec 29, 2017$53.12M+145.3%
2016Dec 30, 2016$21.66M+196.4%
2015Dec 31, 2015$7.31M-90.0%
2014Dec 31, 2014$73.38M-78.1%
2013Dec 31, 2013$334.47M–

More CV Sciences figures

See a number that looks wrong?